Longer Gleevec Use Ups Survival in Gut Tumor (CME/CE)
(MedPage Today) — Adjuvant imatinib (Gleevec) treatment given for a longer period of time was superior to therapy for only a year following surgery for gastrointestinal stromal tumors, an open-label study found.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com